RT Book, Section
A1 Dalmau, Josep
A1 Rosenfeld, Myrna R.
A2 Longo, Dan L.
SR Print(0)
ID 1135230592
T1 Paraneoplastic Neurologic Syndromes and Autoimmune Encephalitis
T2 Harrison's Hematology and Oncology, 3e
YR 2016
FD 2016
PB McGraw-Hill Education
PP New York, NY
SN 9781259835834
LK hemonc.mhmedical.com/content.aspx?aid=1135230592
RD 2024/04/23
AB Paraneoplastic  neurologic  disorders  (PNDs)  are  cancer-related  syndromes  that  can  affect  any  part  of  the  nervous  system  (Table  55-1).  They  are  caused  by  mechanisms  other  than  metastasis  or  by  any  of  the  complications  of  cancer  such  as  coagulopathy,  stroke,  metabolic  and  nutritional  conditions,  infections,  and  side  effects  of  cancer  therapy.  In  60%  of  patients,  the  neurologic  symptoms  precede  the  cancer  diagnosis.  Clinically  disabling  PNDs  occur  in  0.5–1%  of  all  cancer  patients,  but  they  affect  2–3%  of  patients  with  neuroblastoma  or  small-cell  lung  cancer  (SCLC)  and  30–50%  of  patients  with  thymoma  or  sclerotic  myeloma.